Abstract submission
Global Health EDCTP3 invites submission of abstracts for oral presentations or poster presentations of original contributions on innovations and impact in global health research, relevant to the scope of Global Health EDCTP3 Strategic Research and Innovation Agenda. Researchers working on projects supported under EDCTP2, Global Health EDCTP3 and other related Horizon Europe programmes are encouraged to use this opportunity to share new developments and results from their projects. We also welcome submissions from stakeholders working worldwide on health research in Africa. The Call for abstracts is currently open and will close on 23 February 2025.
Please read the information below carefully before submitting an abstract:
Format and eligibility
Abstracts must be submitted in English and should not exceed 300 words.
Abstracts should follow the format:
- Background
- Methods
- Results
- Conclusions
Abstracts must not have been published or submitted for presentation to any other national or international meeting.
Submission
Abstracts must be submitted via the online system by 23 February 2025. Only abstracts submitted online by the deadline will be considered. No changes to abstracts will be accepted after the submission deadline. Detailed instructions are available in the online submission system. For questions regarding abstracts, please contact info@edctpforum.eu.
Evaluation procedure
All submitted abstracts will be reviewed by the Programme Committee and external experts, in collaboration with Global Health EDCTP3. Selection of abstracts will be based on the following criteria:
- Abstract quality
- Relevance to the Forum theme and Global Health EDCTP3 activities
- Significance of the reported results.
The corresponding author will be notified of the outcome of the review by April 2025.
Please note that the final decision on whether the abstract is accepted and, if so, whether it will be for a poster or oral presentation will be made by Global Health EDCTP3 and the Programme Committee. It is expected that presenters will attend in person. Poster presenters will be allocated a time slot where they will present and address questions in person at the Forum.
Presenting authors whose abstracts have been accepted will receive further instructions for presenting their abstracts.
Publication
Global Health EDCTP3 intends to publish the accepted abstracts in a Forum programme booklet and as a journal supplement. Declaration of agreement to the publication’s terms and conditions will be requested at the time of acceptance of your abstract.
Financial support
Global Health EDCTP3 will support transport, accommodation and visa costs for a limited number of early and mid-career investigators with high-ranking abstracts, who have been accepted to present an abstract at the Twelfth EDCTP Forum. Access to all Forum sessions and meals as per the Forum programme are also foreseen. This support is intended for investigators with limited research funding. Selected recipients will be the primary authors of oral or poster presentations.
Applications for financial support must be accompanied by the following supporting documents, merged into a single PDF:
I) Up-to-date CV and concise summary of the applicant’s career to date
II) Motivation letter addressing the following topics:
- Future career plans and how attendance at the Forum will assist in developing the applicant’s career
- Benefit of attendance to the applicant’s institution
III) Support letter from the Head of Department. This letter must be printed on the institutional letterhead.
Selection procedure
Selection of recipients for financial support will be based on the following criteria:
- Abstract and scholarship application quality
- Relevance to the Forum theme and to Global Health EDCTP3 Strategic Research and Innovation Agenda
- Significance of research results
- The potential benefit of attendance to the applicant, his/her colleagues, institution, and wider community
- Geography and gender, as the Forum aims to maximise participation across sub-Saharan Africa and ensure gender balance.
Recipients will be notified by April 2025.
Abstract application form
This page will take you through the process of submitting your abstract. At any time in the process, you can click the ‘Save & continue later’ button to save your incomplete submission and return to it later. Once all required sections have been completed, you can submit your abstract by clicking the ‘Save & submit’ button.
Title
The title cannot be longer than the specified number of words (word limit: 25).
Category/subcategory
Please choose one category/subcategory combination from the list below. The chosen category/subcategory should be the most appropriate fit with your abstract content and will be used for programme planning.
Advancing biomedical innovations
- A1 – Advances in vaccines & neutralising antibodies development
- A2 – Advances in drug development and tackling antimicrobial resistance
- A3 – Advances in diagnostic development
- A4- Coinfections and comorbidities
Knowledge translation and implementation science for public health impact
- B1 – Implementation science and national health research systems
- B2 – Maternal and child health
- B3 – Climate crisis, pandemics/epidemics and health
Strengthening the research environment, research capacity and scientific leadership
- C1 – Strengthening the ethics, regulatory and pharmacovigilance framework in Africa
- C2 – Innovations in capacity strengthening, including digital technologies
- C3 – Partnerships and alliances to enhance coordination, collaboration and cooperation
Equitable and ethical research
- D1 – Ethics and human rights, including community engagement and good participatory practice in research
- D2 – Advancing women in global health research
- D3 – Equitable access to medical interventions
Affiliations
Enter the details for each author/co-author: Email, First name, Last name, Phone, Title, Organisation, City, Country.
Abstract upload
Guidelines on submitting the abstract
- Abstracts must be submitted in English.
- Abstracts must not exceed a 300-word limit. The word limit relates only to the text of the abstract and does not include the title, sub-headings, authors, and author address.
- The abstract should not include the title, authors, or affiliations, only the abstract text.
- Images, tables, or graphics are not to be included in the abstract body.
- Abstracts must be free of typographical and grammatical errors.
- Standard abbreviations may be used for common terms only. Otherwise, any abbreviation should be given in brackets after the first full use of the word. Abbreviations may be used in the title, provided the name in full is outlined in the body of the abstract
- It is the presenting author’s responsibility to ensure the title, author, and affiliation details (full name of institution, place, country) entered in the abstract submission site are complete and correct, and exactly as they should be published on the abstract and all Forum materials.
- The funding source for the research presented must be provided.
Additional information
By submitting an abstract, you confirm that you have permission from the authors to submit this abstract on their behalf and that all authors have read and approved the final version of this abstract. The content of the abstract cannot be modified after the submission deadline (unless changes are requested by Global Health EDCTP3).
Resubmission policy
Abstracts must not have been published or submitted for presentation to any other national or international meeting. Any abstract which has been published previously can only be submitted provided that there are new methods, findings, updated information or other valid reasons that can be provided by the author.
Clinical trials
The presenting author confirms that any data or results presented in the abstract pertaining to clinical trial(s) are derived from clinical trials that are registered in a registry that is a primary register of the WHO International Clinical Trials Registry Platform (ICTRP) or in ClinicalTrials.gov, which is a data provider to the WHO ICTRP.
Ethical research declaration
The presenting author confirms that the research presented in this abstract has been conducted in accordance with the protocol approved by the institutional and/or national ethics committee, and in accordance with the Declaration of Helsinki of the World Medical Association. The Programme Committee may contact me to clarify ethical aspects during the abstract review.
Presentation preference
You will be asked to indicate your presentation preference in case your abstract is accepted. Please note that the final decision on whether you are accepted for oral presentation or poster will be made by Global Health EDCTP3. Presenters are expected to attend in person.
Consent
In case your abstract is selected, you agree to provide a biography and photo.
In case your abstract is selected, and following your explicit consent, you will be requested to send to Global Health EDCTP3 your profile photo and your bio for communication purposes via the Global Health EDCTP3 website or other channels. Also, following your explicit consent, your surname, name and affiliation will be published together with your poster in the venue of the Forum and will be announced during the Twelfth EDCTP Forum. In case you would like to withdraw your consent, please send an email to EC-GH-EDCTP3-DATA-PROTECTION@ec.europa.eu.
